ALNY stock news
This page provides real-time market news, earnings updates, and company announcements related to Alnylam Pharmaceuticals, Inc. (ALNY).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-04-15 22:29 EST
ALNY Q4 Earnings Beat, Sales Miss Despite Y/Y Growth, Stock Down
Finviz2026-02-13 16:21:42
Is Alnylam Pharmaceuticals (ALNY) One of the Best Upside Stocks to Invest In Right Now?
Finviz2026-02-14 06:24:02
The S&P 500 index closed roughly flat in early trading, with real estate and financial sectors up 1%, technology up 0.4%, and materials, energy, and consumer staples sectors down as much as 1.6%.
华尔街见闻2026-02-17 21:02:20
Tarsus Pharmaceuticals Appoints Renowned Biopharmaceutical Leader and Former Allergan CEO, David Pyott, to its Board of Directors
Finviz2026-02-18 13:33:35
Alnylam Pharmaceuticals (ALNY) Reports $3B 2025 Revenue Driven by 151% TTR Franchise Surge
Finviz2026-02-20 09:09:41
Tenaya Therapeutics Enters into Research Collaboration with Alnylam Pharmaceuticals to Identify and Validate Novel Genetic Targets for Cardiovascular Disease Therapeutics
Finviz2026-03-05 13:33:09
Tenaya Therapeutics Stock Jumps After New Alnylam Deal
Finviz2026-03-05 18:39:49
BridgeBio's Rare-Disease Pipeline Sparks Growth Buzz
Finviz2026-03-10 19:06:55
Tenaya Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Finviz2026-03-11 20:09:56
Jefferies Group recently announced the initiation of research coverage on Alnylam Pharmaceuticals and assigned a "Hold" rating to its stock.
老虎证券2026-03-16 08:10:00
Arbutus Reports Fourth Quarter and Year End 2025 Financial Results and Provides Corporate Update
Finviz2026-03-23 11:36:10
Alnylam Pharmaceuticals (ALNY) Reports $3B 2025 Revenue Driven by 151% TTR Franchise Surge
Finviz2026-02-20 09:09:41
Tenaya Therapeutics Enters into Research Collaboration with Alnylam Pharmaceuticals to Identify and Validate Novel Genetic Targets for Cardiovascular Disease Therapeutics
Finviz2026-03-05 13:33:09
Tenaya Therapeutics Stock Jumps After New Alnylam Deal
Finviz2026-03-05 18:39:49
BridgeBio's Rare-Disease Pipeline Sparks Growth Buzz
Finviz2026-03-10 19:06:55
Tenaya Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Finviz2026-03-11 20:09:56
Jefferies Group recently announced the initiation of research coverage on Alnylam Pharmaceuticals and assigned a "Hold" rating to its stock.
老虎证券2026-03-16 08:10:00
Arbutus Reports Fourth Quarter and Year End 2025 Financial Results and Provides Corporate Update
Finviz2026-03-23 11:36:10
ALNY stock chart
ALNY stock detailsALNY stock price change
On the last trading day, ALNY stock closed at 339.41 USD, with a price change of 1.92% for the day.
Trade stock perpsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more